Navigation Links
Research show little support for controls on overseas fertility treatment
Date:3/20/2013

PROBLEMS in accessing donor sperm and eggs at home appear to be behind a reported increase in the number of UK citizens who seek fertility treatment abroad, despite the fact that this is widely seen as risky. Now, a team of academic experts, including a University of Huddersfield professor, have investigated the phenomenon and analysed the attitudes of health professionals.

The researchers found little support for legal controls on cross-border fertility treatment, but UK-based clinicians stressed the importance of checking out overseas fertility clinics in order to make sure they meet UK standards and pose minimal risk to patients.

Eric Blyth, who is Professor of Social Work at the University of Huddersfield and an acknowledged expert on issues such as infertility and surrogacy, is a member of a six-strong research team, based at a range of UK universities, which carried out a study into the growth of overseas travel for fertility treatment.

The group has now described its first phase of findings in an article in the 2013 edition of the Journal of Reproductive and Infant Psychology.

There are few robust statistics on the numbers travelling overseas for egg or sperm donation, states the article, but it concludes that "there would appear to be growing international brokering in gametes and overseas clinics, largely driven by the donor shortage in the UK".

Now further research is needed into how professionals and patients "navigate this form of transnational reproduction".

The article claims that media representations of what is often dubbed "fertility tourism" have many of the hallmarks of a "classic moral panic". Despite the fact that IVF is now widely accepted as a legitimate form of reproduction, people who travel overseas to receive it are frequently seen as "deviant users" of the technology, sometimes depicted as selfish "baby shoppers". Sensationalist examples of older mothers and multiple pregnancies are used to bolster such views.

"Those who cross borders for treatment are frequently portrayed as illegitimately challenging nature, or "playing God", in wanting to "design" their babies by selecting their sex or seeking out particular physical or intellectual abilities," states the article.

Professionals in the field take a more complex, nuanced view, but they often represent cross-border reproductive travel as risk-laden.

Concerns expressed include the control of quality and safety standards overseas; the need to protect patients against incompetence and negligence; an alleged lack of psychological support in some clinics; and inadequate information about possible health risks to patients, donors or offspring.

The article stresses that there is no strong evidence to support these fears and that many patients travelling for fertility treatment outside the UK mostly to European destinations felt that they had received a better quality of care.

None of the clinicians surveyed by the research project felt that in an age of easy and affordable travel there would be any purpose in the UK introducing restrictions on overseas fertility treatment, even if it was a procedure that was not legal in Britain. This is because it would be impossible to prove where a child was conceived.

The article's authors state that: "In the absence of formal international regulation of standards and procedures, many participants reflected that professionals had a key role to play in educating people about possible risks and to ensure that patients were aware of the issues that they need to consider when having treatment abroad."


'/>"/>

Contact: John Ramsdin
j.p.ramsdin@hud.ac.uk
01-484-472-693
University of Huddersfield
Source:Eurekalert  

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Researchers develop a new cell and animal model of inflammatory breast cancer
4. Researchers uncover a viable way for colorectal cancer patients to overcome drug resistance
5. Sexually abused boys at risk for more unsafe sex: UBC research
6. Researchers Find Gene Mutations That May Be a Key to Autism
7. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
8. Researchers find evidence of banned antibiotics in poultry products
9. Presidential keynote address and new research highlights from the American Society of Pediatric Otolaryngology meeting
10. Scientific session and new research highlights
11. NJ stroke researchers report advances in spatial neglect research at AAN Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research show little support for controls on overseas fertility treatment
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: